Your trusted destination for CME, CPD & Medical Education across the Middle East.
King Abdulaziz University — Jeddah, Saudi Arabia
Prof. Abdulrahman Alshaikh, MBBS, MRCP, ABIM, FRCP is a Saudi Professor and Consultant in Endocrinology and Diabetes based in Jeddah. His academic affiliation is with King Abdulaziz University, while his current clinical affiliation includes Dr. Soliman Fakeeh Hospital, Jeddah. He has developed a professional career focused on diabetes, endocrinology, metabolic disease and obesity, with particular involvement in diabetes technology, continuous glucose monitoring and regional diabetes-care recommendations.
He is also a board member of the Saudi Scientific Diabetes Society, where he is listed as Professor Abdulrahman Alshaikh, Consultant Endocrinology, King Abdulaziz University.
Position: Professor / Consultant in Endocrinology and Diabetes
His academic profile on Cureus identifies him as a Professor of Diabetes and Endocrinology at King Abdulaziz University Faculty of Medicine, Jeddah.
The Saudi Scientific Diabetes Society also identifies him as a Consultant Endocrinology at King Abdulaziz University.
Position: Consultant Endocrinology
Recent peer-reviewed publications list Dr. Soliman Fakeeh Hospital, Jeddah alongside King Abdulaziz University as his institutional affiliation.
The SAHIM Kick-Off Meeting scientific committee also lists him as:
Prof. Abdulrahman Alshaikh — Consultant Endocrinology, Dr. Soliman Fakeeh Hospital.
Primary academic institution:
King Abdulaziz University, Jeddah, Saudi Arabia
Clinical institution:
Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia
Specialty: Endocrinology, Diabetes & Metabolism
His current publications consistently identify his credentials as:
The 2025 Journal of Diabetes Science and Technology expert statement lists him specifically as Abdulrahman Alshaikh, MBBS, MRCP, ABIM, FRCP.
These credentials indicate medical training followed by postgraduate internal-medicine qualification and specialist certification in endocrinology/diabetes, although I did not find a sufficiently authoritative public CV documenting the exact institutions and dates for each qualification. I therefore would not assign specific graduation years or training hospitals without additional primary-source evidence.
Prof. Alshaikh's principal area is Endocrinology and Diabetes.
His documented professional interests include:
His recent academic work particularly demonstrates expertise in diabetes technology and GCC diabetes care.
Prof. Alshaikh has participated in research and expert-consensus work addressing diabetes and metabolic diseases in Saudi Arabia and across the Gulf region.
In 2025, he was a lead author of the “Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region.”
The paper was published in the Journal of Diabetes Science and Technology and involved diabetes experts from several Gulf countries. It addressed the use of real-time continuous glucose monitoring in people with type 2 diabetes, including intensive insulin therapy and regional considerations for diabetes management.
His affiliations on this publication were:
King Abdulaziz University, Jeddah
Dr. Soliman Fakeeh Hospital, Jeddah.
This is an important recent example of his involvement in developing regional diabetes-care recommendations.
In 2026, Prof. Alshaikh was the lead author of a Gulf Cooperation Council consensus on diabetic peripheral neuropathy.
The publication, “Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council,” was published in the Journal of Diabetes Investigation.
The study brought together diabetes experts from six GCC countries and used a three-round Delphi process to identify gaps in screening, diagnosis and treatment of diabetic peripheral neuropathy.
His listed affiliation was:
Department of Endocrinology, King Abdulaziz University Hospital & Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
This further documents his involvement in regional diabetes policy, clinical consensus and professional education.
Prof. Alshaikh was also a co-author of the 2026 publication:
“Developing a Comprehensive Approach for Managing Cardiorenal Metabolic Diseases in Saudi Arabia: Thinking beyond Single Disease—Literature Review and Multidisciplinary Consensus Report.”
The paper was published in Diabetes Therapy and involved specialists from endocrinology, cardiology, nephrology and other disciplines across Saudi Arabia and internationally.
The work examines a broader cardiorenal-metabolic approach, rather than treating diabetes, cardiovascular disease and renal disease as isolated conditions.
Prof. Alshaikh is a board member of the Saudi Scientific Diabetes Society. The society describes itself as a multidisciplinary scientific society focused on preventing diabetes and its complications through:
Its current board listing identifies Prof. Abdulrahman Alshaikh as a Consultant Endocrinology, King Abdulaziz University.
His participation in the society is consistent with his academic and clinical focus on diabetes and metabolic disease.
Prof. Alshaikh is involved in specialist medical education and scientific meetings in Saudi Arabia.
For example, he is listed on the SAHIM Kick-Off Meeting Scientific Committee, alongside consultants and professors in endocrinology, obesity medicine, cardiology, nephrology and other specialties. The committee listing identifies him as Consultant Endocrinology, Dr. Soliman Fakeeh Hospital.
His involvement in diabetes societies and multidisciplinary scientific committees complements his academic role at King Abdulaziz University.
The publicly accessible sources establish a long-standing academic and clinical association with King Abdulaziz University, but they do not provide a complete chronological CV with every training appointment.
What can be documented reliably is:
He has held an academic position in Endocrinology and Diabetes at King Abdulaziz University Faculty of Medicine, where current professional profiles identify him as a Professor.
He practices as a Consultant Endocrinologist at Dr. Soliman Fakeeh Hospital in Jeddah. This affiliation appears in recent peer-reviewed publications and current scientific committee listings.
He serves on the board of the Saudi Scientific Diabetes Society.
His recent publications demonstrate participation in GCC-wide expert consensus groups, particularly concerning diabetes technology, diabetic neuropathy and cardiorenal-metabolic disease.
Based on his recent publications and professional affiliations, his research interests can be summarized as:
Diabetes
Continuous glucose monitoring
Metabolic medicine
Diabetic complications
GCC diabetes care
These interests are directly reflected in his 2025–2026 publications
Beyond The Thyroid
Beyond The Thyroid